Bottom line
JCRAX vs SBIO: the short answer
JCRAX (ALPS | CoreCommodity Management CompleteCommodities Strategy Fund) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds.
SBIO is cheaper at 0.5% vs 1.42% — a difference of $92 a year per $10,000 invested.
Over five years, JCRAX returned +11.4% a year vs +0.7% for SBIO.
Updated Nov 19, 2026
JCRAX vs SBIO side by side
| JCRAX | SBIO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | American Funds (Capital Group) | Alps |
| Category | Commodities | Health Care Sector |
| Expense ratio | 1.42% | 0.5% |
| Annual cost per $10k | $142 | $50 |
| 10-yr cost on $10k (prospectus) | $1,675 | $628 |
| Max front load | 0% | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +25.3% | +54.2% |
| 5-yr return (annualized) | +11.4% | +0.7% |
| 10-yr return (annualized) | +7.2% | +5.7% |
| Best quarter | +25.5% | +33.9% |
| Worst quarter | −30.3% | −30.8% |
| Net assets (fund) | $979.6M | $161.8M |
| Number of holdings | 124 | 89 |
| Portfolio turnover | 19% | 58% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JCRAX | SBIO | Difference |
|---|---|---|---|
| 2025 | +25.3% | +54.2% | −28.9% |
| 2024 | +1.3% | +4.2% | −2.9% |
| 2023 | −7.4% | +8.2% | −15.6% |
| 2022 | +12.8% | −27.9% | +40.7% |
| 2021 | +29.5% | −17.5% | +47.0% |
| 2020 | +2.2% | +21.2% | −19.1% |
| 2019 | +11.0% | +49.9% | −38.9% |
| 2018 | −14.5% | −11.2% | −3.3% |
| 2017 | +4.6% | +44.9% | −40.3% |
| 2016 | +15.6% | −27.7% | +43.2% |
Source: Fund prospectus bar charts
Holdings overlap
JCRAX and SBIO share none of their top holdings.
JCRAX top 10
- Alps Corecommodity Natural Resources Etf — 37.47%
- Treasury Bill — 17.75%
- Citigroup Inc. — 15.33%
- Treasury Bill — 13.30%
- Royal Bank Of Canada — 9.88%
- Blackrock Liquidity Funds Treasury Trust Fund Portfolio — 7.50%
- Treasury Bill — 7.03%
- BofA Securities, Inc — 6.92%
- Societe General — 5.05%
- Treasury Bill — 4.91%
SBIO top 10
- Alkermes Plc — 4.48%
- Kymera Therapeutics Inc — 4.23%
- Celcuity Inc — 3.92%
- Mirum Pharmaceuticals Inc — 3.90%
- Spyre Therapeutics Inc — 3.68%
- Cg Oncology Inc — 3.35%
- Apogee Therapeutics Inc — 2.93%
- Xenon Pharmaceuticals Inc — 2.90%
- Travere Therapeutics Inc — 2.77%
- Dianthus Therapeutics Inc — 2.64%
FAQ
What is the difference between JCRAX and SBIO?
JCRAX (ALPS | CoreCommodity Management CompleteCommodities Strategy Fund) and SBIO (ALPS Medical Breakthroughs ETF) are both mutual funds. SBIO is cheaper at 0.5% vs 1.42% — a difference of $92 a year per $10,000 invested.
Which is cheaper, JCRAX or SBIO?
SBIO has the lower expense ratio (0.5%).
Should I own both JCRAX and SBIO?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.